JOURNAL OF THE CZECH PEDIATRIC SOCIETY AND THE SLOVAK PEDIATRIC SOCIETY

Čes-slov Pediat 2024, 79(2):85-88 | DOI: 10.55095/CSPediatrie2024/011

Vitamin D in children with inflammatory bowel disease

Miloš Geryk, Eva Karásková
Dětská klinika, Lékařská fakulta, Univerzita Palackého v Olomouci a FN Olomouc

The relationship between inflammatory bowel disease and vitamin D is intensively studied, not only in connection with bone metabolism, but also in relation to immunopathological response in the gastrointestinal tract, intestinal microbiota and therapy of underlying disease. Although it is clear that these patients suffer from vitamin D deficiency, it is not yet fully understood, whether vitamin D replacement leads to an improvement in the clinical condition or prognosis of these patients.

Keywords: vitamin D, inflammatory bowel disease, Crohn's disease, ulcerative colitis, children

Received: January 15, 2024; Revised: January 15, 2024; Accepted: February 5, 2024; Published: April 1, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Geryk M, Karásková E. Vitamin D in children with inflammatory bowel disease. Ces-slov Pediat. 2024;79(2):85-88. doi: 10.55095/CSPediatrie2024/011.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Levine A, Koletzko S, Turner D, et al. European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr 2014; 58(6): 795-806. Go to original source... Go to PubMed...
    2. Jabandziev P, Pinkasova T, Kunovsky L, et al. Regional incidence of inflammatory bowel disease in a Czech pediatric population: 16 years of experience (2002-2017). J Pediatr Gastroenterol Nutr 2020; 70(5): 586-592. Go to original source... Go to PubMed...
    3. Karlinger K, Györke T, Makö E, et al. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol 2000; 35(3): 154-67. Go to original source... Go to PubMed...
    4. Bamias G, Rivera-Nieves J. Vitamin D levels may predict response to vedolizumab. J Crohns Colitis 2021; 15(12): 1978-1979. Go to original source... Go to PubMed...
    5. Vernia F, Valvano M, Longo S, et al. Vitamin D in inflammatory bowel diseases. Mechanisms of action and therapeutic implications. Nutrients 2022; 14(2): 269. Go to original source... Go to PubMed...
    6. Berger MM, Shenkin A, Schweinlin A, et al. ESPEN micronutrient guideline. Clin Nutr 2022; 41(6): 1357-1424. Go to original source... Go to PubMed...
    7. Nielsen OH, Rejnmark L, Moss AC. Role of vitamin D in the natural history of inflammatory bowel disease. J Crohns Colitis 2018; 12(6): 742-752. Go to original source... Go to PubMed...
    8. Limketkai BN, Bechtold ML, Nguyen DL. Vitamin D and the pathogenesis of inflammatory bowel disease. Curr Gastroenterol Rep 2016; 18(10): 52. Go to original source... Go to PubMed...
    9. Triantos C, Aggeletopoulou I, Mantzaris GJ, et al. Molecular basis of vitamin D action in inflammatory bowel disease. Autoimmun Rev 2022; 21(8): 103136. Go to original source... Go to PubMed...
    10. Provvedini DM, Tsoukas CD, Deftos LJ, et al. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 1983; 221(4616): 1181-3. Go to original source... Go to PubMed...
    11. Bhalla AK, Amento EP, Clemens TL, et al. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 1983; 57(6): 1308-10. Go to original source... Go to PubMed...
    12. Reichel H, Koeffler HP, Norman AW. Synthesis in vitro of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by interferon-gamma-stimulated normal human bone marrow and alveolar macrophages. J Biol Chem 1987; 262(23): 10931-7. Go to original source...
    13. Fritsche J, Mondal K, Ehrnsperger A, et al. Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. Blood 2003; 102(9): 3314-6. Go to original source... Go to PubMed...
    14. Kreutz M, Andreesen R, Krause SW, et al. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood 1993; 82(4): 1300-7. Go to original source...
    15. Sadeghi K, Wessner B, Laggner U, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006; 36(2): 361-70. Go to original source... Go to PubMed...
    16. Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164(5): 2405-11. Go to original source... Go to PubMed...
    17. Jeffery LE, Burke F, Mura M, et al. 1,25-dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009; 183(9): 5458-67. Go to original source... Go to PubMed...
    18. Daniel C, Sartory NA, Zahn N, et al. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008; 324(1): 23-33. Go to original source... Go to PubMed...
    19. Palmer MT, Lee YK, Maynard CL, et al. Lineage-specific effects of 1,25-dihydroxyvitamin D(3) on the development of effector CD4 T cells. J Biol Chem 2011; 286(2): 997-1004. Go to original source... Go to PubMed...
    20. Bhalla AK, Amento EP, Krane SM. Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol 1986; 98(2): 311-22. Go to original source... Go to PubMed...
    21. Fletcher J, Cooper SC, Ghosh S, et al. The Role of vitamin D in inflammatory bowel disease: mechanism to management. Nutrients 2019; 11(5): 1019. Go to original source... Go to PubMed...
    22. Aggeletopoulou I, Marangos M, Assimakopoulos SF, et al. Vitamin D and microbiome: molecular interaction in inflammatory bowel disease pathogenesis. Am J Pathol 2023; 193(6): 656-668. Go to original source... Go to PubMed...
    23. Soltys K, Stuchlikova M, Hlavaty T, et al. Seasonal changes of circulating 25-hydroxyvitamin D correlate with the lower gut microbiome composition in inflammatory bowel disease patients. Sci Rep 2020; 10(1): 6024. Go to original source... Go to PubMed...
    24. Schäffler H, Herlemann DP, Klinitzke P, et al. Vitamin D administration leads to a shift of the intestinal bacterial composition in Crohn's disease patients, but not in healthy controls. J Dig Dis 2018; 19(4): 225-234. Go to original source... Go to PubMed...
    25. Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 2012; 142(3): 482-9. Go to original source... Go to PubMed...
    26. Hassan V, Hassan S, Seyed-Javad P, et al. Association between serum 25 (OH) vitamin D concentrations and inflammatory bowel diseases (IBDs) activity. Med J Malaysia 2013; 68(1): 34-8.
    27. Valvano M, Magistroni M, Cesaro N, et al. Effectiveness of vitamin D supplementation on disease course in inflammatory bowel disease patients: systematic review with meta-analysis. Inflamm Bowel Dis 2022: izac253. Go to original source...
    28. Gubatan J, Mitsuhashi S, Zenlea T, et al. Low serum vitamin D during remission increases risk of clinical relapse in patients with ulcerative colitis. Clin Gastroenterol Hepatol 2017; 15(2): 240-246.e1. Go to original source... Go to PubMed...
    29. Lin X, Wu X, Zhang Y, et al. Effect of vitamin D supplementation on clinical course and T helper 17/ T-regulatory balance in peripheral blood of patients with Crohn's disease. Turk J Gastroenterol 2023; 34(5): 463-471. Go to original source... Go to PubMed...
    30. de Bruyn JR, Bossuyt P, Ferrante M, et al. Dutch-Belgian The Effect of Vitamin D3 to Prevent Postoperative Relapse of Crohn's Disease: A Placebo-controlled Randomized Trial Study Group. High-dose vitamin D does not prevent postoperative recurrence of Crohn's disease in a randomized placebo-controlled trial. Clin Gastroenterol Hepatol 2021; 19(8): 1573-1582.e5. Go to original source... Go to PubMed...
    31. Gordon RJ, Wells R, Johansen C, et al. Efficacy and safety of high-dose cholecalciferol in patients with inflammatory bowel disease receiving infliximab. J Pediatr Gastroenterol Nutr 2022; 74(4): 476-483. Go to original source... Go to PubMed...
    32. Wallace C, Gordon M, Sinopoulou V, et al. Vitamin D for the treatment of inflammatory bowel disease. Cochrane Database Syst Rev 2023; 10(10): CD011806. Go to original source... Go to PubMed...
    33. Hizarcioglu-Gulsen H, Kaplan JL, Moran CJ, et al. The impact of vitamin D on response to anti-tumor necrosis factor-α therapy in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2021; 72(5): e125-e131. Go to original source... Go to PubMed...
    34. Bendix M, Dige A, Jørgensen SP, et al. Seven weeks of high-dose vitamin D treatment reduces the need for infliximab dose-escalation and decreases inflammatory markers in Crohn's disease during one-year follow-up. Nutrients 2021; 13(4): 1083. Go to original source... Go to PubMed...
    35. Chanchlani N, Lin S, Smith R, t al. Pretreatment vitamin D concentrations do not predict therapeutic outcome to anti-TNF therapies in biologic-naïve patients with active luminal Crohn's disease. Crohns Colitis 360 2023; 5(3): otad026. Go to original source... Go to PubMed...
    36. Gubatan J, Rubin SJS, Bai L, et al. Vitamin D is associated with α4β7+ immunophenotypes and predicts vedolizumab therapy failure in patients with inflammatory bowel disease. J Crohns Colitis 2021; 15(12): 1980-1990. Go to original source... Go to PubMed...
    37. Olczyk M, Czkwianianc E, Socha-Banasiak A. Metabolic bone disorders in children with inflammatory bowel diseases. Life (Basel) 2022; 12(3): 423. Go to original source... Go to PubMed...
    38. Sylvester FA, Wyzga N, Hyams JS, et al. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflamm Bowel Dis 2007; 13(1): 42-50. Go to original source... Go to PubMed...
    39. Jin HY, Lim JS, Lee Y, et al. Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease. BMC Pediatr 2021; 21(1): 35. Go to original source... Go to PubMed...
    40. Masip E, Donat E, Polo Miquel B, et al. Bone mineral density in spanish children at the diagnosis of inflammatory bowel disease. Arch Osteoporos 2021; 16(1): 96. Go to original source... Go to PubMed...
    41. Kärnsund S, Lo B, Bendtsen F, et al. Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease. World J Gastroenterol 2020; 26(35): 5362-5374. Go to original source... Go to PubMed...
    42. Kappelman MD, Galanko JA, Porter CQ, et al. Risk of diagnosed fractures in children with inflammatory bowel diseases. Inflamm Bowel Dis 2011; 17(5): 1125-30. Go to original source... Go to PubMed...
    43. Bernstein CN, Blanchard JF, Leslie W, et al. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med 2000; 133(10): 795-9. Go to original source... Go to PubMed...
    44. Hradsky O, Soucek O, Maratova K, et al. Supplementation with 2000 IU of cholecalciferol is associated with improvement of trabecular bone mineral density and muscle power in pediatric patients with IBD. Inflamm Bowel Dis 2017; 23(4): 514-523. Go to original source... Go to PubMed...
    45. Miele E, Shamir R, Aloi M, et al. Nutrition in pediatric inflammatory bowel disease: a position paper on behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018; 66(4): 687-708. Go to original source... Go to PubMed...
    46. Maratová K, Hradský O, Souček O, et al. Vitamin D a jeho suplementace u dětských pacientů se zánětlivým střevním onemocněním. Pediatr praxi 2018; 19(4): 190-194. Go to original source...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content